UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Trends in pharmacological sciences (Regular ed.), ISSN 0165-6147, 2006, Volume 27, Issue 4, pp. 211 - 217
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - drug therapy | Apoptosis - drug effects | Humans | Lung Neoplasms - metabolism | Carcinoma, Non-Small-Cell Lung - metabolism | Lung Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Purinergic P2 Receptor Agonists | Receptors, Purinergic P2 - drug effects | Randomized Controlled Trials as Topic | Adenosine Triphosphate - pharmacology | Neoplasms, Experimental - pathology | Adenosine Triphosphate - therapeutic use | Animals | Signal Transduction - drug effects | Cell Differentiation - drug effects | Receptors, Purinergic P2 - metabolism | Cell Line, Tumor | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasms, Experimental - metabolism | Neoplasms, Experimental - drug therapy | Causes of | Cell receptors | Research | Cancer | Cell research | Care and treatment | Analysis | Oncology, Experimental | Index Medicus
Journal Article
Purinergic signalling, ISSN 1573-9538, 9/2012, Volume 8, Issue 3, pp. 419 - 436
Clinical trials, nucleosides | Neurosciences | Adenosine receptors | Human Physiology | P2Y receptors | Antagonists | Nucleotides | Biomedicine general | Biomedicine | GPCR structure | Cancer Research | Agonists | Pharmacology/Toxicology | Biochemistry & Molecular Biology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Receptors, G-Protein-Coupled - metabolism | Humans | Purinergic P2Y Receptor Agonists - therapeutic use | Purinergic P1 Receptor Agonists - therapeutic use | Purinergic P1 Receptor Antagonists - pharmacology | Receptors, Purinergic P1 - chemistry | Receptors, Purinergic P2 - chemistry | Drug Design | Receptors, G-Protein-Coupled - drug effects | Purinergic P2Y Receptor Antagonists - therapeutic use | Purinergic P2Y Receptor Antagonists - pharmacology | Purinergic P1 Receptor Agonists - chemistry | Purinergic P1 Receptor Agonists - pharmacology | Purinergic P1 Receptor Antagonists - therapeutic use | Purinergic P2Y Receptor Agonists - chemistry | Clinical Trials as Topic | Receptors, Purinergic P2 - drug effects | Purinergic P2Y Receptor Agonists - pharmacology | Animals | Purinergic P2Y Receptor Antagonists - chemistry | Receptors, Purinergic P2 - metabolism | Ligands | Receptors, Purinergic P1 - metabolism | Receptors, Purinergic P1 - drug effects | Receptors, G-Protein-Coupled - chemistry | Purinergic P1 Receptor Antagonists - chemistry | Glaucoma | Heart | Adenosine | Parkinson's disease | Psoriasis | Cystic fibrosis | Rheumatoid factor | Hepatitis | Alkaloids | Pyrimidines | Heterocyclic compounds | Emissions (Pollution) | Rheumatoid arthritis | Respiratory tract diseases | Eye diseases | G proteins | Diabetes | Ophthalmology | Kidney diseases | Hepatitis C | DNA-ligand interactions | Index Medicus | Arrhythmia | Clinical trials | Ionizing radiation | Reperfusion | Ischemia | pyrimidines | Injuries | Movement disorders | Neurodegenerative diseases | Diabetes mellitus | Lung diseases | Pharmacology | Thrombosis | imaging | Stress | Purine P2Y receptors | purines | Hypoxia | Receptor mechanisms | ATP | Cancer | Pharmaceuticals | Original
Journal Article
Neuropharmacology, ISSN 0028-3908, 2011, Volume 61, Issue 1, pp. 25 - 34
Adenosine | Biosensors | ATP | P2Y | P2X | Seizures | Pharmacology & Pharmacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Electric Stimulation - adverse effects | Seizures - prevention & control | Purines - pharmacology | Rats | Male | Purinergic P2 Receptor Antagonists - therapeutic use | Receptors, Purinergic P2 - physiology | Hippocampus - drug effects | Rats, Sprague-Dawley | Seizures - physiopathology | Purinergic P2 Receptor Agonists - therapeutic use | Animals | Seizures - etiology | Purinergic P2 Receptor Antagonists - pharmacology | Biosensing Techniques - methods | Purinergic P2 Receptor Agonists - pharmacology | Purines - therapeutic use | Hippocampus - physiopathology | Organ Culture Techniques | Medical equipment | Alkaloids | Seizures (Medicine) | Physiological apparatus | Index Medicus | Adenosine A1 receptors | Brain slice preparation | Antagonists | Electrical stimuli | Purine P2X receptors | Anticonvulsants | Purine P2Y receptors | Sensory neurons | purines | Purine P2 receptors
Journal Article
Current medicinal chemistry, ISSN 0929-8673, 2015, Volume 22, Issue 7, pp. 915 - 928
P2X7 | P2X receptor agonists | P2X6 | P2X3 | P2X2 | P2X5 | P2X4 | P2X receptor antagonists | P2X1 | Pharmacology & Pharmacy | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Animals | Receptors, Purinergic P2X - chemistry | Humans | Purinergic P2X Receptor Agonists - chemistry | Purinergic P2 Receptor Antagonists - pharmacology | Receptors, Purinergic P2X - metabolism | Purinergic P2 Receptor Antagonists - chemistry | Purinergic P2X Receptor Agonists - pharmacology
Journal Article
The Journal of biological chemistry, ISSN 0021-9258, 05/2004, Volume 279, Issue 19, pp. 20234 - 20241
Up-Regulation | Lung - pathology | Epithelial Cells - metabolism | Adenosine Monophosphate - metabolism | Cystic Fibrosis - metabolism | Humans | Cells, Cultured | Inflammation | Purinergic P2 Receptor Agonists | Chromatography, High Pressure Liquid | Nucleotides - metabolism | RNA, Messenger - metabolism | Cilia - metabolism | Ribonucleases - metabolism | Mucous Membrane - pathology | Time Factors | Adenosine Triphosphate - metabolism | Adenosine - metabolism | Bronchi - metabolism | Adenosine Diphosphate - metabolism | Index Medicus
Journal Article
Cellular and molecular life sciences : CMLS, ISSN 1420-682X, 06/2007, Volume 64, Issue 12, pp. 1471 - 1483
Biochemistry, general | G protein-coupled receptors | heteromultimers | P2X receptor | Biomedicine general | Cell Biology | Life Sciences | Life Sciences, general | gene regulation | P2Y receptor | P1 receptor | Cloned receptors | ion channel receptors | Heteromultimers | Gene regulation | Ion channel receptors | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Purines - metabolism | Humans | Transcriptional Activation | Gene Expression Regulation | Purinergic P2 Receptor Agonists | Pyrimidines - metabolism | Receptors, Purinergic P1 - chemistry | Receptors, Purinergic P2 - chemistry | Animals | Adenosine Triphosphate - metabolism | Receptors, Purinergic P2 - metabolism | Receptors, Purinergic P1 - metabolism | Purinergic P1 Receptor Agonists | Dimerization | Ions | Molecular biology | Cloning | Genomics | Index Medicus
Journal Article
Bioconjugate chemistry, ISSN 1043-1802, 08/2009, Volume 20, Issue 8, pp. 1650 - 1659
Uridine Diphosphate Glucuronic Acid - chemistry | Polyamines - chemistry | Uridine Diphosphate Glucuronic Acid - pharmacology | Humans | Molecular Conformation | Cells, Cultured | Structure-Activity Relationship | Purinergic P2 Receptor Agonists - chemistry | Receptors, Purinergic P2 - chemistry | Polyamines - pharmacology | Receptors, Purinergic P2 - metabolism | Dendrimers - chemistry | Purinergic P2 Receptor Agonists - pharmacology | Dendrimers - pharmacology | Index Medicus
Journal Article
The Journal of biological chemistry, ISSN 0021-9258, 11/2008, Volume 283, Issue 45, pp. 30933 - 30941
Humans | Uridine Triphosphate - pharmacology | Cercopithecus aethiops | Arrestins - genetics | Protein Transport - physiology | Protein Transport - drug effects | Purinergic P2 Receptor Agonists | Arrestins - metabolism | Catalytic Domain - physiology | Adenosine Diphosphate - pharmacology | Animals | Signal Transduction - drug effects | beta-Arrestin 2 | beta-Arrestin 1 | beta-Arrestins | Receptors, Purinergic P2 - genetics | Receptors, Purinergic P2 - metabolism | Signal Transduction - physiology | COS Cells | Index Medicus
Journal Article
The FASEB journal, ISSN 0892-6638, 08/2003, Volume 17, Issue 11, pp. 1401 - 1410
bone | ecto-NDPK | ATP | ADP | ecto-nucleoside diphosphokinase | Ecto-nucleoside diphosphokinase | Bone | Ecto-NDPK | Biochemistry & Molecular Biology | Biology | Life Sciences & Biomedicine - Other Topics | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Nucleoside-Diphosphate Kinase - biosynthesis | Guanosine Triphosphate - pharmacology | Humans | Culture Media, Conditioned - chemistry | Receptors, Purinergic P2Y1 | Adenosine Triphosphate - biosynthesis | RNA, Messenger - metabolism | Dose-Response Relationship, Drug | Receptors, Purinergic P2 - biosynthesis | Adenosine Triphosphate - metabolism | Cell Division | Receptors, Purinergic P2 - genetics | Monomeric GTP-Binding Proteins - biosynthesis | Receptors, Purinergic P2Y12 | Nucleoside-Diphosphate Kinase - genetics | Cell Line | Osteoblasts - enzymology | Adenosine Triphosphate - analysis | Osteoblasts - drug effects | Cells, Cultured | Purinergic P2 Receptor Antagonists | Transcription Factors - biosynthesis | Purinergic P2 Receptor Agonists | Monomeric GTP-Binding Proteins - genetics | Transcription Factors - genetics | Membrane Proteins | Cell Membrane - enzymology | NM23 Nucleoside Diphosphate Kinases | Adenosine Diphosphate - metabolism | Osteoblasts - metabolism | Index Medicus
Journal Article
Pharmacological reviews, ISSN 0031-6997, 09/2006, Volume 58, Issue 3, pp. 281 - 341
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Cardiovascular Diseases - etiology | Atherosclerosis - drug therapy | Cardiovascular Diseases - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Gene Expression Regulation | Models, Molecular | Purinergic P2 Receptor Antagonists | Receptors, Purinergic P2 - physiology | Ion Channels - physiology | Purinergic P2 Receptor Agonists | Phylogeny | Receptors, Purinergic P2 - classification | Protein Isoforms - physiology | Tissue Distribution | Receptors, Purinergic P2 - therapeutic use | Animals | Models, Biological | Second Messenger Systems - physiology | Atherosclerosis - prevention & control | Index Medicus
Journal Article